Insider Shareholders with Direct Ownership of Dyne Therapeutics, Inc. (DYN)
This section provides a comprehensive overview of the insiders with direct ownership of Dyne Therapeutics, Inc. (DYN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Dyne Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 0 | 2,442,039 | 6,815,965 $164 Million | 10 |
Feb 20, 2024
Reduced 0.05%
|
|
|
Atlas Venture Opportunity Fund Ii, L.P.
> 10% Shareholder |
934,581 | 0 | 934,581 $22.4 Million | 1 |
Dec 12, 2022
Added 50.0%
|
|
Joshua T Brumm
CEO & President |
1,916,277 | 1,485,306 | 537,998 $12.9 Million | 41 |
Mar 11, 2024
Reduced 1.58%
|
|
Oxana Beskrovnaya
Chief Scientific Officer |
335,168 | 152,772 | 201,685 $4.84 Million | 31 |
Dec 11, 2024
Reduced 1.14%
|
|
John Cox
CEO & President |
145,300 | 0 | 150,300 $3.61 Million | 1 |
Dec 04, 2024
Added 49.15%
|
|
Wildon Farwell
Chief Medical Officer |
190,819 | 47,597 | 143,222 $3.44 Million | 23 |
Aug 19, 2024
Reduced 0.18%
|
|
Jonathan Mc Neill
Chief Business Officer |
347,822 | 252,626 | 132,106 $3.17 Million | 39 |
Aug 19, 2024
Reduced 0.23%
|
|
Susanna Gatti High
Chief Operating Officer |
339,158 | 243,426 | 131,636 $3.16 Million | 31 |
Sep 18, 2024
Reduced 3.4%
|
|
Richard William Scalzo
SVP, Head of Finance & Admin. |
451,608 | 335,995 | 127,078 $3.05 Million | 43 |
Dec 11, 2024
Reduced 1.13%
|
|
Johanna Friedl Naderer
Chief Commercial Officer |
96,200 | 0 | 96,200 $2.31 Million | 2 |
Dec 04, 2024
Added 28.21%
|
|
Douglas Kerr
Chief Medical Officer |
95,500 | 0 | 95,500 $2.29 Million | 2 |
Dec 04, 2024
Added 33.45%
|
| 0 | 29,435 | 0 $0 | 1 |
N/A
|
|
| 16,500 | 16,500 | 0 $0 | 2 |
Nov 18, 2024
Reduced 100.0%
|